title: Infliximab in a patient with ankylosing spondylitis and secondary IgA nephropathy requiring haemodialysis.
authors.forename: Elisa
authors.initials: E
authors.lastname: Marocchi
authors.forename: Antonio
authors.initials: A
authors.lastname: Spadaro
authors.forename: Konstantinos
authors.initials: K
authors.lastname: Giannakakis
authors.forename: Roberta
authors.initials: R
authors.lastname: Priori
authors.forename: Guido
authors.initials: G
authors.lastname: Valesini
mesh_terms: D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D018501:Antirheumatic Agents / Q000627:therapeutic use*; D005922:Glomerulonephritis, IGA / Q000209:etiology* / Q000473:pathology / Q000628:therapy; D006801:Humans; D000069285:Infliximab; D007676:Kidney Failure, Chronic / Q000209:etiology / Q000473:pathology / Q000628:therapy; D008297:Male; D008875:Middle Aged; D006435:Renal Dialysis; D013167:Spondylitis, Ankylosing / Q000150:complications* / Q000188:drug therapy*
chemical_list: D000911:Antibodies, Monoclonal; D018501:Antirheumatic Agents; D000069285:Infliximab